Diabetes, Vol 35, Issue 8 855-860, Copyright © 1986 by American Diabetes Association

ARTICLES

Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice

LS Wicker, BJ Miller and Y Mullen

The nonobese diabetic (NOD) mouse, a model of human type I diabetes, develops insulitis beginning at 4-6 wk of age. By 30 wk of age, 72% of females and 39% of males develop spontaneous diabetes, apparently because of an overwhelming autoimmune response to the insulin-producing beta-cells within the islets. To identify the immune mechanism responsible for destruction of beta-cells in the NOD mouse, we developed an adoptive transfer protocol that induces diabetes in NOD mice at an age when spontaneous diabetes is rarely observed. Splenocytes from overtly diabetic NOD mice were unable to transfer diabetes to very young (less than or equal to 6 wk) irradiated NOD mice but effectively transferred diabetes to irradiated NOD mice greater than 6 wk of age. In such transfers, overt diabetes was induced within 12-22 days in greater than 95% (79/82) of the recipients. Thus, transfer of splenocytes to young mice induces them to become diabetic at a higher frequency and at a younger age than their untreated littermates. Equally successful transfers with as few as 5 X 10(6) spleen cells have been performed in male and female NOD mice, even though males display a lower spontaneous incidence of diabetes than females. Splenocytes obtained from diabetic mice maintained on insulin for up to 2 mo also transferred diabetes. Because NOD mice display increasing levels of insulitis with age, spleen cells obtained from nondiabetic NOD mice of different ages were tested for their ability to transfer diabetes.(ABSTRACT TRUNCATED AT 250 WORDS)
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				L. Li, B. Wang, J. A. Frelinger, and R. Tisch T-Cell Promiscuity in Autoimmune Diabetes Diabetes, August 1, 2008; 57(8): 2099 - 2106. [Abstract] [Full Text] [PDF]

				A. P. Martin, M. G. Grisotto, C. Canasto-Chibuque, S. L. Kunkel, J. S. Bromberg, G. C. Furtado, and S. A. Lira Islet Expression of M3 Uncovers a Key Role for Chemokines in the Development and Recruitment of Diabetogenic Cells in NOD Mice Diabetes, February 1, 2008; 57(2): 387 - 394. [Abstract] [Full Text] [PDF]

				R. Li, N. Perez, S. Karumuthil-Melethil, and C. Vasu Bone Marrow Is a Preferential Homing Site for Autoreactive T-Cells in Type 1 Diabetes Diabetes, September 1, 2007; 56(9): 2251 - 2259. [Abstract] [Full Text] [PDF]

				M. J. Perone, S. Bertera, Z. S. Tawadrous, W. J. Shufesky, J. D. Piganelli, L. G. Baum, M. Trucco, and A. E. Morelli Dendritic Cells Expressing Transgenic Galectin-1 Delay Onset of Autoimmune Diabetes in Mice J. Immunol., October 15, 2006; 177(8): 5278 - 5289. [Abstract] [Full Text] [PDF]

				G. Nussbaum, A. Zanin-Zhorov, F. Quintana, O. Lider, and I. R. Cohen Peptide p277 of HSP60 signals T cells: inhibition of inflammatory chemotaxis Int. Immunol., October 1, 2006; 18(10): 1413 - 1419. [Abstract] [Full Text] [PDF]

				D. Bruder, A. M. Westendorf, W. Hansen, S. Prettin, A. D. Gruber, Y. Qian, H. von Boehmer, K. Mahnke, and J. Buer On the Edge of Autoimmunity: T-Cell Stimulation by Steady-State Dendritic Cells Prevents Autoimmune Diabetes Diabetes, December 1, 2005; 54(12): 3395 - 3401. [Abstract] [Full Text] [PDF]

				T. Griseri, L. Beaudoin, J. Novak, L. T. Mars, F. Lepault, R. Liblau, and A. Lehuen Invariant NKT Cells Exacerbate Type 1 Diabetes Induced by CD8 T Cells J. Immunol., August 15, 2005; 175(4): 2091 - 2101. [Abstract] [Full Text] [PDF]

				S. You, M. Belghith, S. Cobbold, M.-A. Alyanakian, C. Gouarin, S. Barriot, C. Garcia, H. Waldmann, J.-F. Bach, and L. Chatenoud Autoimmune Diabetes Onset Results From Qualitative Rather Than Quantitative Age-Dependent Changes in Pathogenic T-Cells Diabetes, May 1, 2005; 54(5): 1415 - 1422. [Abstract] [Full Text] [PDF]

				S. You, G. Slehoffer, S. Barriot, J.-F. Bach, and L. Chatenoud Unique role of CD4+CD62L+ regulatory T cells in the control of autoimmune diabetes in T cell receptor transgenic mice PNAS, October 5, 2004; 101(suppl_2): 14580 - 14585. [Abstract] [Full Text] [PDF]

				S. Koarada, Y. Wu, N. Fertig, D. A. Sass, M. Nalesnik, J. A. Todd, P. A. Lyons, J. Fenyk-Melody, D. B. Rainbow, L. S. Wicker, et al. Genetic Control of Autoimmunity: Protection from Diabetes, but Spontaneous Autoimmune Biliary Disease in a Nonobese Diabetic Congenic Strain J. Immunol., August 15, 2004; 173(4): 2315 - 2323. [Abstract] [Full Text] [PDF]

				I-F. Lee, H. Qin, J. Trudeau, J. Dutz, and R. Tan Regulation of Autoimmune Diabetes by Complete Freund's Adjuvant Is Mediated by NK Cells J. Immunol., January 15, 2004; 172(2): 937 - 942. [Abstract] [Full Text] [PDF]

				M A Kelly, M L Rayner, C H Mijovic, and A H Barnett Molecular aspects of type 1 diabetes Mol. Pathol., February 1, 2003; 56(1): 1 - 10. [Abstract] [Full Text] [PDF]

				A. M. Alexander, M. Crawford, S. Bertera, W. A. Rudert, O. Takikawa, P. D. Robbins, and M. Trucco Indoleamine 2,3-Dioxygenase Expression in Transplanted NOD Islets Prolongs Graft Survival After Adoptive Transfer of Diabetogenic Splenocytes Diabetes, February 1, 2002; 51(2): 356 - 365. [Abstract] [Full Text] [PDF]

				S. Winer, I. Astsaturov, R. Gaedigk, D. Hammond-McKibben, M. Pilon, A. Song, V. Kubiak, W. Karges, E. Arpaia, C. McKerlie, et al. ICA69null Nonobese Diabetic Mice Develop Diabetes, but Resist Disease Acceleration by Cyclophosphamide J. Immunol., January 1, 2002; 168(1): 475 - 482. [Abstract] [Full Text] [PDF]

				S. Kommajosyula, S. Reddy, K. Nitschke, J. R. Kanwar, M. Karanam, and G. W. Krissansen Leukocytes infiltrating the pancreatic islets of nonobese diabetic mice are transformed into inactive exiles by combinational anti-cell adhesion therapy J. Leukoc. Biol., October 1, 2001; 70(4): 510 - 517. [Abstract] [Full Text] [PDF]

				A. M. Yamamoto, Y. Chernajovsky, F. Lepault, O. Podhajcer, M. Feldmann, J.-F. Bach, and L. Chatenoud The Activity of Immunoregulatory T Cells Mediating Active Tolerance Is Potentiated in Nonobese Diabetic Mice by an IL-4-Based Retroviral Gene Therapy J. Immunol., April 15, 2001; 166(8): 4973 - 4980. [Abstract] [Full Text] [PDF]

				P. P.L. Chiu, D. V. Serreze, and J. S. Danska Development and Function of Diabetogenic T-cells in B-cell-Deficient Nonobese Diabetic Mice Diabetes, April 1, 2001; 50(4): 763 - 770. [Abstract] [Full Text]

				K. Suk, S. Kim, Y.-H. Kim, K.-A. Kim, I. Chang, H. Yagita, M. Shong, and M.-S. Lee IFN-{{gamma}}/TNF-{{alpha}} Synergism as the Final Effector in Autoimmune Diabetes: A Key Role for STAT1/IFN Regulatory Factor-1 Pathway in Pancreatic {{beta}} Cell Death J. Immunol., April 1, 2001; 166(7): 4481 - 4489. [Abstract] [Full Text] [PDF]

				C. M. Dobbs and K. Haskins Comparison of a T Cell Clone and of T Cells from a TCR Transgenic Mouse: TCR Transgenic T Cells Specific for Self-Antigen Are Atypical J. Immunol., February 15, 2001; 166(4): 2495 - 2504. [Abstract] [Full Text] [PDF]

				P. Chaturvedi, B. Agrawal, M. Zechel, E. Lee-Chan, and B. Singh A Self MHC Class II {beta}-Chain Peptide Prevents Diabetes in Nonobese Diabetic Mice J. Immunol., June 15, 2000; 164(12): 6610 - 6620. [Abstract] [Full Text] [PDF]

				S. Kim, K.-A. Kim, D.-Y. Hwang, T. H. Lee, N. Kayagaki, H. Yagita, and M.-S. Lee Inhibition of Autoimmune Diabetes by Fas Ligand: The Paradox Is Solved J. Immunol., March 15, 2000; 164(6): 2931 - 2936. [Abstract] [Full Text] [PDF]

				M. Poulin and K. Haskins Induction of Diabetes in Nonobese Diabetic Mice by Th2 T Cell Clones from a TCR Transgenic Mouse J. Immunol., March 15, 2000; 164(6): 3072 - 3078. [Abstract] [Full Text] [PDF]

				X. Su, Q. Hu, J. M. Kristan, C. Costa, Y. Shen, D. Gero, L. A. Matis, and Y. Wang Significant Role for Fas in the Pathogenesis of Autoimmune Diabetes J. Immunol., March 1, 2000; 164(5): 2523 - 2532. [Abstract] [Full Text] [PDF]

				F. Lepault and M. C. Gagnerault Characterization of Peripheral Regulatory CD4+ T Cells That Prevent Diabetes Onset in Nonobese Diabetic Mice J. Immunol., January 1, 2000; 164(1): 240 - 247. [Abstract] [Full Text] [PDF]

				K. Lejon C. and G. Fathman Isolation of Self Antigen-Reactive Cells from Inflamed Islets of Nonobese Diabetic Mice Using CD4high Expression as a Marker J. Immunol., November 15, 1999; 163(10): 5708 - 5714. [Abstract] [Full Text] [PDF]

				Y. SEGEV, D. LANDAU, R. RASCH, A. FLYVBJERG, and M. PHILLIP Growth Hormone Receptor Antagonism Prevents Early Renal in Nonobese Diabetic Mice J. Am. Soc. Nephrol., November 1, 1999; 10(11): 2374 - 2381. [Abstract] [Full Text]

				X. X. Zheng, A. W. Steele, W. W. Hancock, K. Kawamoto, X. C. Li, P. W. Nickerson, Y. Li, Y. Tian, and T. B. Strom IL-2 Receptor-Targeted Cytolytic IL-2/Fc Fusion Protein Treatment Blocks Diabetogenic Autoimmunity in Nonobese Diabetic Mice J. Immunol., October 1, 1999; 163(7): 4041 - 4048. [Abstract] [Full Text] [PDF]

				A. Mayer, F. Rharbaoui, C. Thivolet, J. Orgiazzi, and A. M. Madec The Relationship between Peripheral T Cell Reactivity to Insulin, Clinical Remissions and Cytokine Production in Type 1 (Insulin-Dependent) Diabetes Mellitus J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2419 - 2424. [Abstract] [Full Text]

				J. Allison and A. Strasser Mechanisms of beta  cell death in diabetes: A minor role for CD95 PNAS, November 10, 1998; 95(23): 13818 - 13822. [Abstract] [Full Text] [PDF]

				B. Balasa, J. D. Davies, J. Lee, A. Good, B. T. Yeung, and N. Sarvetnick IL-10 Impacts Autoimmune Diabetes Via a CD8+ T Cell Pathway Circumventing the Requirement for CD4+ T and B Lymphocytes J. Immunol., October 15, 1998; 161(8): 4420 - 4427. [Abstract] [Full Text] [PDF]

				A. Herbelin, J.-M. Gombert, F. Lepault, J.-F. Bach, and L. Chatenoud Mature Mainstream TCR{alpha}{beta}+CD4+ Thymocytes Expressing L-Selectin Mediate ""Active Tolerance"" in the Nonobese Diabetic Mouse J. Immunol., September 1, 1998; 161(5): 2620 - 2628. [Abstract] [Full Text] [PDF]

				K. J.L. Hammond, L. D. Poulton, L. J. Palmisano, P. A. Silveira, D. I. Godfrey, and A. G. Baxter alpha /beta -T Cell Receptor (TCR)+CD4-CD8- (NKT) Thymocytes Prevent Insulin-dependent Diabetes Mellitus in Nonobese Diabetic (NOD)/Lt Mice by the Influence of Interleukin (IL)-4 and/or IL-10 J. Exp. Med., April 6, 1998; 187(7): 1047 - 1056. [Abstract] [Full Text] [PDF]

				N. Itoh, A. Imagawa, T. Hanafusa, M. Waguri, K. Yamamoto, H. Iwahashi, M. Moriwaki, H. Nakajima, J. Miyagawa, M. Namba, et al. Requirement of Fas for the Development of Autoimmune Diabetes in Nonobese Diabetic Mice J. Exp. Med., August 18, 1997; 186(4): 613 - 618. [Abstract] [Full Text] [PDF]

				I. Bergerot, C. Ploix, J. Petersen, V. Moulin, C. Rask, N. Fabien, M. Lindblad, A. Mayer, C. Czerkinsky, J. Holmgren, et al. A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes PNAS, April 29, 1997; 94(9): 4610 - 4614. [Abstract] [Full Text] [PDF]

				L. C. Harrison, M. Dempsey-Collier, D. R. Kramer, and K. Takahashi Aerosol Insulin Induces Regulatory CD8 gamma delta T Cells That Prevent Murine Insulin-dependent Diabetes J. Exp. Med., December 15, 1996; 184(6): 2167 - 2174. [Abstract] [Full Text] [PDF]

				K Haskins and M McDuffie Acceleration of diabetes in young NOD mice with a CD4+ islet-specific T cell clone Science, September 21, 1990; 249(4975): 1433 - 1436. [Abstract] [PDF]

				J Bohme, B Schuhbaur, O Kanagawa, C Benoist, and D Mathis MHC-linked protection from diabetes dissociated from clonal deletion of T cells Science, July 20, 1990; 249(4966): 293 - 295. [Abstract] [PDF]

				A. Sinha, M. Lopez, and H. McDevitt Autoimmune diseases: the failure of self tolerance Science, June 15, 1990; 248(4961): 1380 - 1388. [Abstract] [PDF]

				J Bohme, K Haskins, P Stecha, W van Ewijk, M LeMeur, P Gerlinger, C Benoist, and D Mathis Transgenic mice with I-A on islet cells are normoglycemic but immunologically intolerant Science, June 9, 1989; 244(4909): 1179 - 1183. [Abstract] [PDF]

				J. Salaun, N. Simmenauer, P. Belo, A. Coutinho, and N. M. Le Douarin Grafts of supplementary thymuses injected with allogeneic pancreatic islets protect nonobese diabetic mice against diabetes PNAS, January 22, 2002; 99(2): 874 - 877. [Abstract] [Full Text] [PDF]